Fact CheckerSign in

NCT07040618Recruiting

Rhomboid Intercostal Block vs Erector Spinae Block

Assessing the Effectiveness of Rhomboid Intercostal and Erector Spinae Plane Blocks After Lung Cancer Thoracotomy

Source: ClinicalTrials.gov · Last updated 1 Sept 2026

Brief summary (registry, in English)

This randomized trial compares rhomboid intercostal block (RIB) and erector spinae plane block (ESPB) for postoperative pain control in lung cancer patients undergoing thoracotomy. Sixty patients will be assessed for 24-hour morphine consumption, pain scores, hemodynamics, recovery time, satisfaction, and side effects. The study aims to identify the more effective technique for enhancing recovery and minimizing opioid use.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
18 Jun 2025
Start date
1 Jul 2025
Primary completion date
1 Jan 2027
Lead sponsor
Cairo University
Diseases
Lung cancer
NCT number
NCT07040618

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Jul 2025 to the primary completion date, 1 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known allergy or contraindication to local anesthetics or opioids used in the study
  • History of chronic pain or psychological disorders
  • Contraindications to regional anesthesia (e.g., local infection, coagulopathy, pre-existing peripheral neuropathy)
  • Severe respiratory, cardiac, hepatic, or renal disease

Age

  • Age \< 18 years or \> 65 years

Other

  • Patient refusal
  • ASA physical status IV
  • BMI \< 20 kg/m² or \> 35 kg/m²
  • \-

Who the study is looking for

  • patients undergoing thoracotomy for lung cancer
    • Age ≥ 18 years and ≤ 65 years
    • ASA physical status II or III
    • Body Mass Index (BMI) \> 20 kg/m² and \< 35 kg/m²
    • Willing and able to provide informed consent

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Cancer Institute - Cairo University
Coordinator of this site? Confirm its status
CairoEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.